POSTN + cancer-associated fibroblasts determine the efficacy of immunotherapy in hepatocellular carcinoma.
Hao WangYuan LiangZheng LiuRui ZhangJiashuo ChaoMingming WangMu LiuLei QiaoZhengfeng XuanHaitao ZhaoLing LuPublished in: Journal for immunotherapy of cancer (2024)
Our research elucidates light on the role of a particular subset of CAFs in immunotherapy resistance, emphasizing the potential benefits of targeting specific CAF subpopulations to improve clinical responses to immunotherapy.